Matches in Wikidata for { <http://www.wikidata.org/entity/Q58737092> ?p ?o ?g. }
Showing items 1 to 66 of
66
with 100 items per page.
- Q58737092 description "article scientifique publié en 2018" @default.
- Q58737092 description "im Jahr 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q58737092 description "scholarly article published in NPJ aging and mechanisms of disease" @default.
- Q58737092 description "wetenschappelijk artikel" @default.
- Q58737092 description "наукова стаття, опублікована у 2018" @default.
- Q58737092 name "Erratum: Author Correction: Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study" @default.
- Q58737092 name "Erratum: Author Correction: Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study" @default.
- Q58737092 type Item @default.
- Q58737092 label "Erratum: Author Correction: Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study" @default.
- Q58737092 label "Erratum: Author Correction: Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study" @default.
- Q58737092 prefLabel "Erratum: Author Correction: Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study" @default.
- Q58737092 prefLabel "Erratum: Author Correction: Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study" @default.
- Q58737092 P1433 Q58737092-AD27A015-8673-4574-ADBC-24E62C184EBE @default.
- Q58737092 P1476 Q58737092-41B0FFA9-2345-471A-93CD-216EACB0698B @default.
- Q58737092 P2093 Q58737092-30B06769-5ED7-4CC4-B09E-0637FC63B8ED @default.
- Q58737092 P2093 Q58737092-E2B53125-255C-4D21-A87B-9FF2CECF8DAD @default.
- Q58737092 P275 Q58737092-2c513b32-6302-4a33-917e-91caa53afa7d @default.
- Q58737092 P2888 Q58737092-03150BBB-C955-4AE5-A657-EF334F3C28CE @default.
- Q58737092 P304 Q58737092-5BD4AC3D-010F-45E2-B4DE-79342EB71F2F @default.
- Q58737092 P31 Q58737092-1E81D0A6-2FCC-4282-938E-523CC23B4D24 @default.
- Q58737092 P31 Q58737092-6B7A3C6E-8642-410F-92DF-740C31BDD64E @default.
- Q58737092 P356 Q58737092-04F3AD8F-EBED-4E4A-BD16-690A66FC10BF @default.
- Q58737092 P407 Q58737092-CADC09FE-A7ED-464E-9601-188B982EEB61 @default.
- Q58737092 P433 Q58737092-01E7790A-2439-4864-9EB4-D95C5563B5E5 @default.
- Q58737092 P478 Q58737092-271463DD-FFF0-44E5-B3D1-0336A95422B5 @default.
- Q58737092 P50 Q58737092-08CCFC1C-CF3C-4987-9200-E8602A69AD2E @default.
- Q58737092 P50 Q58737092-17740857-58BB-46FF-A659-CF4C687D6C79 @default.
- Q58737092 P50 Q58737092-6E42B425-1F9E-4BE3-987B-4DC098259BD1 @default.
- Q58737092 P50 Q58737092-7B74C2E4-12EC-4FB6-AB57-8C16AAE1ABE4 @default.
- Q58737092 P50 Q58737092-D9D804E2-9AF6-47A0-A25C-3FE825C91C26 @default.
- Q58737092 P577 Q58737092-4E0BF1FF-C27D-4D09-92E2-D61E9CA56C04 @default.
- Q58737092 P6179 Q58737092-A039F7E9-0BFC-446D-9FAB-013B924E8908 @default.
- Q58737092 P6216 Q58737092-7aa93e97-ad1e-4d89-920f-d40e33485b36 @default.
- Q58737092 P698 Q58737092-58949C97-C393-48AA-B417-5B1D1C13E324 @default.
- Q58737092 P921 Q58737092-8CF169AB-005B-4E58-BC11-D575EA6871ED @default.
- Q58737092 P921 Q58737092-A9C9F3FD-E444-4B74-8ABD-CB041BEBA402 @default.
- Q58737092 P921 Q58737092-B9D68677-8201-44D3-8B35-9F62D17620C7 @default.
- Q58737092 P932 Q58737092-4EB32CD7-1A5B-443F-9970-1A006890B266 @default.
- Q58737092 P356 S41514-018-0027-1 @default.
- Q58737092 P698 30155270 @default.
- Q58737092 P1433 Q27727292 @default.
- Q58737092 P1476 "Erratum: Author Correction: Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study" @default.
- Q58737092 P2093 "Mal Evans" @default.
- Q58737092 P2093 "Mark Morris" @default.
- Q58737092 P275 Q20007257 @default.
- Q58737092 P2888 s41514-018-0027-1 @default.
- Q58737092 P304 "8" @default.
- Q58737092 P31 Q13442814 @default.
- Q58737092 P31 Q1348305 @default.
- Q58737092 P356 "10.1038/S41514-018-0027-1" @default.
- Q58737092 P407 Q1860 @default.
- Q58737092 P433 "1" @default.
- Q58737092 P478 "4" @default.
- Q58737092 P50 Q125271091 @default.
- Q58737092 P50 Q125271158 @default.
- Q58737092 P50 Q125271169 @default.
- Q58737092 P50 Q125271227 @default.
- Q58737092 P50 Q6525606 @default.
- Q58737092 P577 "2018-01-01T00:00:00Z" @default.
- Q58737092 P6179 "1106160273" @default.
- Q58737092 P6216 Q50423863 @default.
- Q58737092 P698 "30155270" @default.
- Q58737092 P921 Q192423 @default.
- Q58737092 P921 Q269829 @default.
- Q58737092 P921 Q47262257 @default.
- Q58737092 P932 "6102308" @default.